Dr. Christine's Track Record
Over the past 35 years, Dr. Christine Boers-Doets has provided key stakeholders in the cancer medication chain, like pharma & biotech, regulatory authorities, insurance, healthcare providers, patients and their support system, turnaround strategies on how to turn adverse events into favorable events. Operating at the forefront of systemic cancer treatment, these key stakeholders often experience lack of scientifically proven and practical strategies how to manage adverse events effectively. Inherently, the unresolved adverse events limit the outcome of the lifesaving and life prolonging anticancer treatments. By applying Dr. Christine Boers-Doets's expertise, knowledge and experience, by leveraging the global networks and by supporting stakeholders in making congruent strategic choices, Dr. Boers-Doets has succeeded in building a robust adverse event turnaround track record.